(Q39649942)

13 September 2017

1 reference

title

Neuroendocrine manifestations of congestive heart failure (English)

1 reference

13 September 2017

0 references

congestive heart failure

1 reference

Francis GS

1

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

American Journal of Cardiology

13 September 2017

published in

1 reference

13 September 2017

volume

62

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

9A-13A

1 reference

Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Increased plasma arginine vasopressin levels in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

The Neurohumoral Axis in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Hemodynamic effects of infused arginine vasopressin in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Atrial natriuretic peptide elevation in congestive heart failure in the human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Plasma norepinephrine in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Defective cardiac parasympathetic control in patients with heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

The autonomic nervous system in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Pheochromocytoma masquerading as a cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

The effects of bromocriptine in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Myocardial beta-adrenergic receptor downregulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Myocardial Performance and Extracellular Ionized Calcium in a Severely Failing Human Heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Concentration of renin in renal venous blood in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Hormones and the pathogenesis of congestive heart failure: vasopressin, aldosterone, and angiotensin II. Further evidence for renal-adrenal interaction from studies in hypertension and in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Direct versus indirect pressor and vasoconstrictor actions of angiotensin in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Plasma ADH level in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Arginine vasopressin and the renal response to water loading in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

The Role of Centralα1- andα2-Adrenoceptors in the Regulation of Vasopressin Release and the Cardiovascular System*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Platelet alpha2 adrenoreceptors in chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Inhibition of vasopressin action by atrial natriuretic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Neurohumoral mechanisms involved in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

Interrelationships among prostaglandins and vasoactive substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980078-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(88)80078-X

1 reference

13 September 2017

1 reference